NCT00775203View on ClinicalTrials.gov

A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

PHASE3CompletedINTERVENTIONAL

Enrollment

412

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Major Depressive Disorder

Interventions

DRUG

Trazodone Hydrochloride (HCl) Extended-Release Tablets

DRUG

Placebo

Trial Locations (36)

10021

New York

11235

Brooklyn

19149

Philadelphia

30060

Marietta

30080

Smyrna

30328

Atlanta

32216

Jacksonville

32607

Gainesville

32806

Orlando

33013

Hialeah

33613

Tampa

35216

Birmingham

44122

Beachwood

45242

Cincinnati

45408

Dayton

46202

Indianapolis

60048

Libertyville

66212

Overland Park

73103

Oklahoma City

77401

Bellaire

78229

San Antonio

80212

Denver

90210

Beverly Hills

91506

Burbank

92108

San Diego

85206-4616

Mesa

08021

Clementon

05091

Woodstock

V1Y2H4

Kelowna

V2A5C8

Penticton

A1N1W7

Mount Pearl

L8L5G8

Hamilton

L6J3J4

Oakville

J9A1K7

Gatineau

H1S3A9

Saint-Léonard

J1H4J6

Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Labopharm Inc.

INDUSTRY

NCT00775203 - A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder. | Biotech Hunter | Biotech Hunter